Skip to main content
. 2018 May 26;16(6):184. doi: 10.3390/md16060184

Figure 1.

Figure 1

Effect of docosahexaenoic acid sn1-monoacylglyceride (MAG-DHA) supplementation on lipid profile of erythrocytes in Cystic Fibrosis (CF) patients. (A) Quantitative analyses of relative DHA levels in erythrocytes (RBC) and (B) relative AA/DHA ratio in erythrocytes derived from healthy subjects (n = 6), CF patients of placebo group before (T0, n = 5) and after supplementation for 30 days (T30, n = 5) and 60 days (T60, n = 2), as well as from CF patients of MAG-DHA group before (T0, n = 6) and after supplementation for 30 days (T30, n = 6) and 60 days (T60, n = 3), * p < 0.05.